Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital‐based case‐control study and a population‐based cohort study
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objectives: This study aimed to investigate the association between proton pump inhibitor (PPI) use and risk of sensorineural hearing loss (SNHL) or tinnitus in patients with type 2 diabetes using hospital‐ and population‐based data. Methods: For the case‐control study using the Asan Biomedical Research Environment database, the characteristics between cases and sex‐, age‐ and index‐year‐matched controls were compared by the chi‐squared test. Conditional logistic regression was used to estimate the odds ratios (ORs). For the cohort study using the Korean National Health Insurance Service – National Sample Cohort, the hazard ratios (HRs) for SNHL or tinnitus associated with PPI use were analysed by the Cox proportional hazard regression model. Results: The case‐control study included 1379 cases and 5512 matched controls. After adjustment, PPI use was associated with an increased risk of SNHL or tinnitus (OR 1.61, 95% confidence interval [CI] 1.30‐1.99). The ORs were higher for current or recent use of PPI and high average daily dose. In the cohort study including 17 233 pairs of PPI users and nonusers after propensity score matching, the risk of SNHL or tinnitus increased in PPI users compared with nonusers (HR 1.50, 95% CI 1.40‐1.61). In the stratified analyses, risks remained significant and the magnitude of association was relatively high in those of younger age, patients without gastroesophageal reflux disease and patients not receiving histamine 2 receptor blockers. Conclusions: Our study suggests that PPI use is associated with an increased risk of SNHL or tinnitus. Given the widespread use of PPIs, the potential ototoxic effects of PPIs remain an important concern.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering PPI can affect cardiovascular system, PPI may affect the circulation defect of the cochlea and lead to tinnitus onset29,30.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
In the citing paper
“Although the mechanism is still unknown, the possible mechanism is that PPI may directly act to inner ear physiology by inhibiting H, K-ATPase in the lateral wall of cochlear29.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
In the citing paper
“Our result is in line with previous study showing the PPI medication is associated with tinnitus onset in type 2 diabetes patients29.”
From Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study (2024) · cites this paper as [29]
Citations
Cites
Cohort Profile: The National Health Insurance Service–National Sample Cohort (NHIS-NSC), South Korea
Lee, J., Lee, J. S., Park, S.-H., Shin, S. A., & Kim, K. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv319 · Cited by 1,469
Baguley, D., McFerran, D., & Hall, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60142-7 · Cited by 1,245
Tinnitus: causes and clinical management
Langguth, B., Kreuzer, P. M., Kleinjung, T., & De Ridder, D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70160-1 · Cited by 799
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 604
Pharmacology of proton pump inhibitors
Shin, J. M., & Sachs, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0098-4 · Cited by 538
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14747 · Cited by 423
A unified approach to measuring the effect size between two groups using SAS
Yang, D., & Dalton, J. E. (2012) · Cited by 419
Kedika, R. R., Souza, R. F., & Spechler, S. J. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0951-9 · Cited by 324
Rybak, L. P., & Ramkumar, V. (2007) · Kidney International · doi:10.1038/sj.ki.5002434 · Cited by 298
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15537 · Cited by 278
Infections and Diabetes: Mechanisms and Prospects for Prevention
Pozzilli, P., & Leslie, R. D. G. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00250.x · Cited by 257
Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., Leiper, J., & Cooke, J. P. (2013) · Circulation · doi:10.1161/circulationaha.113.003602 · Cited by 255
Disorders of cochlear blood flow
Nakashima, T., Naganawa, S., Sone, M., Tominaga, M., Hayashi, H., Yamamoto, H., Liu, X., & Nuttall, A. L. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00189-9 · Cited by 253
Cianfrone, G., Pentangelo, D., Cianfrone, F., Mazzei, F., Turchetta, R., Orlando, M. P., & ALTISSIMI, G. (2011) · PubMed · Cited by 240
Adverse Effects Associated With Proton Pump Inhibitors
Schoenfeld, A. J., & Grady, D. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7927 · Cited by 213
Adverse Effects Associated with Proton Pump Inhibitor Use
Yibirin, M., Oliveira, D. D., Valera, R. J., Plitt, A. E., & Lutgen, S. (2021) · Cureus · doi:10.7759/cureus.12759 · Cited by 205
Effects of Type 2 Diabetes Mellitus on Cochlear Structure in Humans
Fukushima, H., Cureoglu, S., Schachern, P. A., Paparella, M. M., Harada, T., & Oktay, M. F. (2006) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.132.9.934 · Cited by 191
Proton pump inhibitors: potential adverse effects
Abraham, N. S. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328358d5b9 · Cited by 140
Gastroesophageal Reflux and Eustachian Tube Dysfunction in an Animal Model
White, D. R., Heavner, S. B., Hardy, S. M., & Prazma, J. P. (2002) · The Laryngoscope · doi:10.1097/00005537-200206000-00004 · Cited by 113
Rosen, R., Hu, L., Amirault, J., Khatwa, U., Ward, D. V., & Onderdonk, A. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.067 · Cited by 105
A 5-Year Prospective Study of Diabetes and Hearing Loss in a Veteran Population
Vaughan, N., James, K. E., McDERMOTT, D. J., Griest, S. E., & Fausti, S. A. (2005) · Otology & Neurotology · doi:10.1097/01.mao.0000194812.69556.74 · Cited by 91
Huo, X., Zhang, X., Yu, C., Zhang, Q., Cheng, E., Wang, D. H., Pham, T. H., Spechler, S. J., & Souza, R. F. (2013) · Gut · doi:10.1136/gutjnl-2013-305533 · Cited by 75
Makunts, T., Alpatty, S. M., Lee, K. C., Atayee, R. S., & Abagyan, R. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53622-3 · Cited by 69
Sensorineural Hearing Loss-A Common Finding in Early-Onset Type 2 Diabetes Me Llitus
Lerman‐Garber, I., Ramos, D. C., Valdés, S., Enríquez, L., Lobato, M., Osornio, M., Escobedo, A. R., Pascual‐Ramos, V., Mehta, R., Ramírez-Anguiano, J., et al. (2012) · Endocrine Practice · doi:10.4158/ep11389.or · Cited by 64
Effects of Diabetes on Hearing and Cochlear Structures
Li, X., Li, R., Meng, L., Yanzhuo, Z., Kaosan, G., & Li-ping, W. (2013) · Journal of Otology · doi:10.1016/s1672-2930(13)50017-1 · Cited by 64
Abrahami, D., McDonald, E. G., Schnitzer, M. E., & Azoulay, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041529 · Cited by 60
Cardiovascular Risk of Proton Pump Inhibitors
Ariel, H., & Cooke, J. P. (2019) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-15-3-214 · Cited by 59
Heavner, S. B., Hardy, S. M., Prazma, J. P., White, D. R., & Pillsbury, H. C. (2001) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940111001007 · Cited by 59
Shibata, T. K., Hibino, H., Doi, K., Suzuki, T., Hisa, Y., & Kurachi, Y. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00266.2006 · Cited by 51
Changes of the Permeability of Round Window Membrane in Otitis Media
Ikeda, K., & Morizono, T. (1988) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1988.01860200079023 · Cited by 48
Characteristics Desired in Clinical Data Warehouse for Biomedical Research
Shin, S.-Y., Kim, W. S., & Lee, J. (2014) · Healthcare Informatics Research · doi:10.4258/hir.2014.20.2.109 · Cited by 46
Hegarty, J. P., Sangster, W., Harris, L., & Stewart, D. B. (2014) · Surgery · doi:10.1016/j.surg.2014.06.074 · Cited by 37
Diagnosis and management of hearing loss in elderly patients.
Phan, N. T., McKenzie, J., Huang, L. L., Whitfield, B. C. S., & Chang, A. (2016) · PubMed · Cited by 31
Gastroesophageal reflux and sequelae of chronic tubotympanal disorders in children
Velepic, M. M., Velepic, M. S., Starčević, R., Manestar, D., & Rožmanić, V. (2004) · Acta Oto-Laryngologica · doi:10.1080/00016480410022499 · Cited by 30
Gastric proton pump is expressed in the inner ear and choroid plexus of the rat
Lecain, É., Robert, J., Thomas, A., & Huy, P. T. B. (2000) · Hearing Research · doi:10.1016/s0378-5955(00)00174-x · Cited by 26
Analysis of the audiological characteristics and comorbidity in patients with chronic tinnitus
Pavaci, S., Tortorella, F., Fioretti, A. B., Angelone, A. M., Businco, L. D. R., Lauriello, M., & Eibenstein, A. (2019) · Audiology Research · doi:10.4081/audiores.2019.231 · Cited by 22
Lin, B. M., Curhan, S. G., Wang, M., Jacobson, B. C., Eavey, R., Stankovic, K. M., & Curhan, G. C. (2017) · Ear & Hearing · doi:10.1097/aud.0000000000000347 · Cited by 17
Başoğlu, M. S., Eren, E., Aslan, H., Kolatan, H. E., Özbay, C., İnan, S., Karaca, F., Öztürkcan, S., & Katılmış, H. (2012) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2011.10.001 · Cited by 13
Oto-Toxic Effect of Gastric Reflux
Develioglu, O. N., Yilmaz, M., Caglar, E., Topak, M., & Kulekci, M. (2013) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31827c7dad · Cited by 10
Impact of early gastroesophageal reflux disease on childhood otologic outcomes
Lee, J. A., Schaffer, C. E., Mehta, C. H., Close, M. F., Nguyen, S. A., & Meyer, T. A. (2020) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2020.110069 · Cited by 7
Kekilli, M., Tanoğlu, A., Öcal, S., & Beyazıt, Y. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013520596 · Cited by 4
Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users
Pirodda, A., Raimondi, M. C., Cicero, A. F. G., Rosticci, M., Rinaldi, E. R., Bellacosa, L., Stanghellini, V., & Borghi, C. (2014) · Hearing Balance and Communication · doi:10.3109/21695717.2014.902554 · Cited by 3
D’Agostino (1998) · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
Research works printed but not linked: 3
- World Health Organization, 2021, Deafness and hearing loss factsheet
- WHO Collaborating Centre for Drug Statistics Methodology, 2018, Defined daily doses
- UpToDate, 2021, Main causes of sudden sensorineural hearing loss
Cited by
Diabetes mellitus and hearing loss
Deng, Y., Chen, S., & Hu, J. P. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00737-z · Cited by 74
Kang, S.-W., An, M. H., Ha, S., Kim, M.-G., Park, T. J., Kim, H. K., Sheen, K., Park, R. W., & Park, S. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-81658-7 · Cited by 4
Proton pump inhibitors: Weighing the benefits and risks across various health conditions
Sizgoric, L., & Likić, R. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15960 · Cited by 4
Kim, S. Y., Yoo, D. M., Kwon, M. J., Kim, J. H., Kim, J., Lee, J. S., & Choi, H. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610280 · Cited by 3
Proton pump inhibitors and risk of hearing loss; a systematic review
Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A. (2025) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-025-04241-5 · Cited by 2
Metadata
- Authors
- Yee, J., Han, H. W., & Gwak, H. S.
- Affiliations
- Ewha Womans University (KR)
- Corresponding author
- Gwak, Hye Sun
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2022-01-13
- Volume
- 88
- Issue
- 6
- Pages
- 2738-2746
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W4205497638
- Semantic Scholar
- 074584f8c5b03e7ebdfcc7b59fced7a016e42330
- Cited by
- 11
- References
- 44
- Citations by year
- 2025: 6 · 2024: 2 · 2023: 2 · 2022: 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- proton pump inhibitors, sensorineural hearing loss, tinnitus, type 2 diabetes, ototoxicity, drug safety, H2 receptor antagonists, gastroesophageal reflux disease, dose-response relationship
- MeSH terms
- Diabetes Mellitus, Type 2, Hospitals, Humans, Risk Factors, Tinnitus, Cohort Studies, Case-Control Studies, Hearing Loss, Proton Pump Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.